Rokugawa Takemi, Konishi Haruyo, Ito Miwa, Iimori Hitoshi, Nagai Ryohei, Shimosegawa Eku, Hatazawa Jun, Abe Kohji
Translational Research Unit, Biomarker R&D Department, Shionogi & Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.
Obesity and Metabolic Diseases, Drug Discovery and Disease Research Laboratory, Shionogi & Co., Ltd., Osaka, Japan.
EJNMMI Res. 2018 May 31;8(1):40. doi: 10.1186/s13550-018-0394-4.
Activated hepatic stellate cells (HSCs), which express integrin αvβ3, are a major fibrogenic factor in NASH pathophysiology. F-labeled cyclic arginine-glycine-aspartic acid penta-peptide (F-FPP-RGD) has been used as a PET probe for tumors expressing integrin αvβ3. The aim of this study was to assess the potential of PET with F-FPP-RGD to detect hepatic integrin αvβ3 expression in non-alcoholic steatohepatitis (NASH) model mice.
Thirty-two male C57BL/6 mice aged 6 weeks were fed a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) for 3 and 8 weeks. F-FPP-RGD PET imaging of the liver was performed at 3 and 8 weeks after CDAHFD feeding. After PET scanning, levels of hepatic integrin αvβ, 3α-smooth muscle actin (α-SMA), and collagen type 1 alpha 1(col1a1) were measured. Histopathological analysis of hepatic steatosis, inflammation, and fibrosis, as well as blood biochemistry analysis, was also performed. CDAHFD for 3 and 8 weeks produced a moderate-to-severe steatosis and inflammation of the liver in mice. NAFLD activity score (NAS) in mice fed the CDAHFD for 3 and 8 weeks were more than 4 indicating NASH or borderline NASH pathology. Fibrosis was observed only in mice fed the CDAHFD for 8 weeks. PET imaging showed that the hepatic standardized uptake value, SUV, was increased with prolonged CDAHFD feeding compared with the respective controls (CDAHFD 3 weeks 0.32 ± 0.06 vs 0.48 ± 0.05, p < 0.01; CDAHFD 8 weeks 0.35 ± 0.04 vs 0.75 ± 0.07, p < 0.01, respectively). Prolonged CDAHFD feeding increased hepatic mRNA and protein levels of integrin αv and β3 at 3 and 8 weeks. Hepatic F-FPP-RGD uptake and amount of integrin αv and β3 protein were well correlated (r = 0.593, p < 0.05 and r = 0.835, p < 0.001, respectively). Hepatic F-FPP-RGD uptake also showed a positive correlation with Sirius red-positive area.
The hepatic uptake of F-FPP-RGD correlated well with integrin αv and β3 expression and histological fibrosis in a mouse model of NASH, suggesting the predictability of fibrosis in NASH pathology.
表达整合素αvβ3的活化肝星状细胞(HSCs)是NASH病理生理学中的主要促纤维化因子。F标记的环精氨酸-甘氨酸-天冬氨酸五肽(F-FPP-RGD)已被用作表达整合素αvβ3的肿瘤的PET探针。本研究的目的是评估F-FPP-RGD PET检测非酒精性脂肪性肝炎(NASH)模型小鼠肝脏整合素αvβ3表达的潜力。
32只6周龄雄性C57BL/6小鼠喂食胆碱缺乏、L-氨基酸限定的高脂饮食(CDAHFD)3周和8周。在CDAHFD喂养3周和8周后对肝脏进行F-FPP-RGD PET成像。PET扫描后,测量肝脏整合素αvβ、3α-平滑肌肌动蛋白(α-SMA)和I型胶原蛋白α1(col1a1)的水平。还进行了肝脏脂肪变性、炎症和纤维化的组织病理学分析以及血液生化分析。CDAHFD喂养3周和8周使小鼠肝脏出现中度至重度脂肪变性和炎症。喂食CDAHFD 3周和8周的小鼠的非酒精性脂肪性肝病活动评分(NAS)超过4,表明为NASH或临界NASH病理。仅在喂食CDAHFD 8周的小鼠中观察到纤维化。PET成像显示,与各自的对照组相比,随着CDAHFD喂养时间延长,肝脏标准化摄取值(SUV)增加(CDAHFD 3周0.32±0.06对0.48±0.05,p<0.01;CDAHFD 8周0.35±0.04对0.75±0.07,p<0.01)。CDAHFD喂养时间延长会增加3周和8周时肝脏整合素αv和β3的mRNA和蛋白水平。肝脏F-FPP-RGD摄取与整合素αv和β3蛋白量具有良好的相关性(分别为r=0.593,p<0.05和r=0.835,p<0.001)。肝脏F-FPP-RGD摄取也与天狼星红阳性面积呈正相关。
在NASH小鼠模型中,肝脏对F-FPP-RGD的摄取与整合素αv和β3表达以及组织学纤维化密切相关,提示NASH病理中纤维化的可预测性。